Online Doctor Consultation: Get expert help from the team of specialized doctors associated with us!

Yes, if the patient requests us to connect him to any reputed doctor we would refer him. Please note that we don’t charge money from the people who approach us.

To register yourself for the Doctor Consultation provided by Vizag Volunteers you have to fill the form above and submit it. Our team will follow up with you and provide proper guidance.

Since we are in the middle of the Covid-19 pandemic, we are only providing Doctor Consultation services to Covid-19 patients. In the future we plan to extend it to other areas of healthcare as well.

No, as per the recent research studies, vaccination doesn’t prevent covid-19 infection in anyone. It can prevent severe disease and hospitalization due to coronavirus infection.

Vaccines have been developed and approved after multiple tests and safety checks. The vaccines approved by the Govt of India are safe and you can opt for any one of those.

The best way to prevent illness is to avoid being exposed to the virus. Follow the below preventive actions:

• Wash your hands often with plain soap and water for at least 20 seconds. If water and soap are not available, use an alcohol based hand sanitizer with at least 60% alcohol.
• Cover your mouth and nose with a cloth face covering or non-surgical mask when around others.
• Get the COVID-19 vaccine when it is offered to you. Once you are fully vaccinated, you may be able to start doing some things that you had stopped doing because of the pandemic.

Monoclonal antibodies are laboratory-produced molecules that act as substitute antibodies that can restore, enhance or mimic the immune system's attack on cells. Monoclonal antibodies for COVID-19 may block the virus that causes COVID-19 from attaching to human cells, making it more difficult for the virus to reproduce and cause harm. Monoclonal antibodies may also neutralize a virus.

Multiple SARS-CoV-2 variants are circulating globally. Some variants contain mutations in the surface spike protein, which mediates viral attachment to human cells and is a target for natural and vaccine-induced immunity. Thus, these variants have the potential to be more transmissible, cause more severe disease, and/or evade natural or vaccine-induced immune responses. Some of the more important circulating variants are:

• Alpha (B.1.1.7 lineage), also known as 20I/501Y.V1, was first identified in the United Kingdom in late 2020. This variant is estimated to be more transmissible than wild-type virus. Some studies suggest this variant may cause more severe illness.
• Delta (B.1.617.2 lineage), also known as 20A/S:478K, was identified in late 2020 in India. This variant is more transmissible than B.1.1.7 and is also associated with more severe disease.
• Omicron (B.1.1.529 lineage) was first reported from southern Africa in November 2021, and it was promptly identified in multiple other countries. The variant contains >30 mutations in the spike protein, including mutations that have been found in other variants of concern and that have been associated with increased transmissibility and decreased susceptibility to neutralizing antibodies (including therapeutic monoclonal antibodies). Emerging data suggest that Omicron has a replication advantage over the Delta variant and evades infection- and vaccine-induced humoral immunity to a greater extent than prior variants. The risk of severe disease with the Omicron variant is more uncertain.